Peripheral/Endo

Boston Scientific Announces Agreement to Acquire VENITI, Inc.

MARLBOROUGH, Mass., Aug. 8, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has signed an agreement to acquire VENITI, Inc., a privately-held company in Fremont, California which has developed and commercialized the VICI VENOUS STENT® System for treating venous obstructive disease. Boston Scientific has been an investor in VENITI since 2016 and currently […]

NexGen Medical Systems, Inc. Launches XCOIL® Large Vessel (18mm) Thrombectomy System

MINNEAPOLIS, Minn., August 6th,2018/         /– NexGen Medical Systems, Inc., a Minneapolis medical device company, announced today the successful completion of the first human use of their XCOIL® Large Vessel (18mm) Thrombectomy System for the treatment of deep vein thrombosis (DVT). The new device, an expansion of the successful XCOIL® 12mm […]

Symposium to Explore the Impact of Vascular Dissections on Critical Limb Ischemia Patients at AMP 2018

WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced key presentations that will be featured during a CME symposium at the Amputation Prevention (AMP) Conference in Chicago on August 8. The symposium, titled “Why Dissections Matter: A case-based look at below-the-knee […]

Corindus to Showcase CorPath GRX® System for Peripheral Vascular Interventions at the 2018 Amputation Prevention Symposium

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that the CorPath GRX System will be showcased for peripheral applications at the 2018 Amputation Prevention Symposium in Chicago, IL. Jihad Mustapha, M.D., Interventional Cardiologist and AMP course director, will moderate an […]

STENTYS Self-Apposing Stents Featured Prominently at MYLIVE 2018 in Malaysia

PARIS–(BUSINESS WIRE)–Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT), a French group specialized in medical technologies for interventional cardiology, today reports activities from MYLIVE 2018, one of the leading Asian congresses in interventional cardiology, held from July 26 to 28, 2018 in Petaling Jaya, Malaysia. The Xposition S sirolimus eluting self-apposing stent was […]

Integer Receives FDA Approval for Thin Wall Radial Introducer Kit, RadialSeal™

PLYMOUTH, Minn., July 31, 2018 (GLOBE NEWSWIRE) — Integer Holdings Corporation (“Integer”) (NYSE:ITGR), a leading medical device outsource manufacturer, announced today that it has received FDA and CE Mark approval for their new radial access introducer, RadialSeal™. The RadialSeal Introducer Kit is founded on Integer’s core technology platforms in guidewires and […]

REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbale Scaffold for Below the Knee Therapy

SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that its MOTIV™ bioresorbable scaffold is the first drug-eluting bioresorbable scaffold to receive CE Mark approval for treatment of below the knee peripheral […]

Clinical Cardiology Publishes Study Demonstrating Simple Blood Test from Prevencio Accurately Detects Cardiovascular Disease

KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc., announces the publication of data that demonstrates a simple new blood test accurately diagnoses significant Peripheral Artery Disease (PAD), a circulatory problem in which plaque-narrowed arteries reduce blood flow to a patient’s limbs and kidneys. If left untreated, PAD can lead to clogged arteries and increase […]

Hancock Jaffe Laboratories Receives Ethics Committee Approval for First-in-Human VenoValve Study

IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that it has received approval from the Ethics Committee at Fundación Santa Fe de Bogotá […]

OPTALYSE PE Results Published in JACC: Cardiovascular Interventions

BOTHELL, Wash.–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global healthcare company, highlighted the publication of OPTALYSE PE trial results in JACC: Cardiovascular Interventions. The published findings further confirm that bilateral pulmonary embolism (PE) treated in as little as 2 hours with EKOSⓇ Acoustic Pulse Thrombolysis™ therapy shows significant improvement in RV/LV ratio and […]